Page last updated: 2024-08-23

tobramycin and Keratoconjunctivitis

tobramycin has been researched along with Keratoconjunctivitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bunce, C; Dahlmann-Noor, A; Hingorani, M; Larkin, F; O'Gallagher, M; Tuft, S	1
Chen, M; Gong, L; Gu, Y; He, X; Qu, J; Sun, X; Wang, L; Zhang, M; Zhong, X	1
Bateman, KM; Comstock, TL; Macy, JI; White, EM	1
Prociv, P	1

Reviews

1 review(s) available for tobramycin and Keratoconjunctivitis

Article	Year
Topical treatments for blepharokeratoconjunctivitis in children. The Cochrane database of systematic reviews, 2017, 02-07, Volume: 2 Topics: Administration, Topical; Anti-Allergic Agents; Anti-Bacterial Agents; Blepharitis; Child; Child, Preschool; Conjunctiva; Eyelids; Humans; Infant; Infant, Newborn; Keratoconjunctivitis; Loteprednol Etabonate; Randomized Controlled Trials as Topic; Tobramycin	2017

Article

Year

Topical treatments for blepharokeratoconjunctivitis in children.

The Cochrane database of systematic reviews, 2017, 02-07, Volume: 2

Topics: Administration, Topical; Anti-Allergic Agents; Anti-Bacterial Agents; Blepharitis; Child; Child, Preschool; Conjunctiva; Eyelids; Humans; Infant; Infant, Newborn; Keratoconjunctivitis; Loteprednol Etabonate; Randomized Controlled Trials as Topic; Tobramycin

2017

Trials

2 trial(s) available for tobramycin and Keratoconjunctivitis

Article	Year
A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis. Current medical research and opinion, 2012, Volume: 28, Issue:3 Topics: Adult; Androstadienes; Anti-Bacterial Agents; Asian People; Dexamethasone; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Keratoconjunctivitis; Loteprednol Etabonate; Male; Middle Aged; Tobramycin; Treatment Outcome	2012
Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blepharitis; Dexamethasone; Drug Combinations; Female; Humans; Intraocular Pressure; Keratoconjunctivitis; Loteprednol Etabonate; Male; Middle Aged; Tobramycin; Treatment Outcome; Visual Acuity	2008

Article

Year

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.

Current medical research and opinion, 2012, Volume: 28, Issue:3

Topics: Adult; Androstadienes; Anti-Bacterial Agents; Asian People; Dexamethasone; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Keratoconjunctivitis; Loteprednol Etabonate; Male; Middle Aged; Tobramycin; Treatment Outcome

2012

Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis.

Current medical research and opinion, 2008, Volume: 24, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blepharitis; Dexamethasone; Drug Combinations; Female; Humans; Intraocular Pressure; Keratoconjunctivitis; Loteprednol Etabonate; Male; Middle Aged; Tobramycin; Treatment Outcome; Visual Acuity

2008

Other Studies

1 other study(ies) available for tobramycin and Keratoconjunctivitis

Article	Year
Pseudomonas aeruginosa keratitis treated with ticarcillin and tobramycin. The Medical journal of Australia, 1979, Jul-28, Volume: 2, Issue:2 Topics: Aged; Anti-Bacterial Agents; Corneal Ulcer; Drug Therapy, Combination; Humans; Keratoconjunctivitis; Male; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin	1979